560
Views
7
CrossRef citations to date
0
Altmetric
Review

An update on neurocritical care for intracerebral hemorrhage

, &
Pages 557-578 | Received 20 Mar 2019, Accepted 10 May 2019, Published online: 21 May 2019

References

  • Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American heart association. Circulation. 2018 Mar 20;137(12):e67–e492. PubMed PMID: 29386200; eng.
  • Rincon F, Mayer SA. The epidemiology of intracerebral hemorrhage in the United States from 1979 to 2008. Neurocrit Care. 2013 Aug;19(1):95–102.. PubMed PMID: 23099848.
  • Krishnamurthi P RV, Feigin MD VL Prof., Forouzanfar MD MH Prof., et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global burden of disease study 2010 [article]. Lancet Glob Health . 2013;1(5):e259–e281. PubMed PMID: edsdoj.404cddc7c0c2428dbc9fa424ed63b45d.
  • van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010 Feb;9(2):167–176. PubMed PMID: 20056489; eng.
  • Ariesen MJ, Claus SP, Rinkel GJE, et al. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003;34(8):2060–2065. 00392499). ;():. PubMed PMID: 106711988. Language: English. Entry Date: 20040312. Revision Date: 20181204. Publication Type: journal article.
  • O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112–123.
  • Brott T, Thalinger K, Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage [Article]. Stroke. 1986 January 01;17(6):1078–1083.. PubMed PMID: edselc.2-52.0-0022895386; English.
  • Sacco S, Marini C, Toni D, et al. Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke. 2009 Feb;40(2):394–399. PubMed PMID: 19038914; eng.
  • Sturgeon JD, Folsom AR, Longstreth WT Jr., et al. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke. 2007 Oct;38(10):2718–2725. PubMed PMID: 17761915.
  • Block F, Dafotakis M. Cerebral amyloid angiopathy in stroke medicine. Dtsch Arztebl Int. 2017 Jan 20;114(3):37–42.. PubMed PMID: 28179050; PubMed Central PMCID: PMCPMC5541242.
  • Charidimou A, Boulouis G, Gurol ME, et al. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain. 2017 Jul 1;140(7):1829–1850. PubMed PMID: 28334869; PubMed Central PMCID: PMCPMC6059159.
  • Mehndiratta P, Manjila S, Ostergard T, et al. Cerebral amyloid angiopathy-associated intracerebral hemorrhage: pathology and management. Neurosurg Focus. 2012 Apr;32(4):E7. PubMed PMID: 22463117.
  • Steiner T, Poli S, Griebe M, et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol . 2016;15(6):566–573. PubMed PMID: 114483654. Language: English. Entry Date: 20180628. Revision Date: 20180801. Publication Type: journal article.
  • Thabet AM, Kottapally M, Hemphill JC 3rd. Management of intracerebral hemorrhage. Handb Clin Neurol. 2017;140:177–194. PubMed PMID: 28187799.
  • Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke . 2015;46(7):2032–2060. PubMed PMID: 26022637.
  • Dastur CK, Yu W. Current management of spontaneous intracerebral haemorrhage. Stroke Vasc Neurol. 2017 Feb 24;2(1):21–29. doi: 10.1136/svn-2016-000047. eCollection 2017 Mar. Review. PubMed PMID: 28959487; PubMed Central PMCID: PMC5435209.
  • Leira R, Castillo J, Dávalos A, et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors [Article]. Neurology. 2004 August 10;63(3):461–467. PubMed PMID: edselc.2-52.0-3543065786; English.
  • Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66(8):1175–1181. PubMed PMID: 106150354. Corporate Author: Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Language: English. Entry Date: 20070907. Revision Date: 20161130. Publication Type: journal article.
  • Gujjar AR, Deibert E, Manno EM, et al. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology. 1998;51(2):447–451. PubMed PMID: 9710017.
  • Wijdicks EFM, Bamlet WR, Maramattom BV, et al. Validation of a new coma scale: the FOUR score. Ann Neurol. 2005;58(4):585–593. PubMed PMID: 106370145. Language: English. Entry Date: 20061208. Revision Date: 20150711. Publication Type: Journal Article.
  • Stead LG, Wijdicks EFM, Bhagra A, et al. Validation of a new coma scale, the FOUR score, in the emergency department [Report]. Neurocrit Care.2009;(1):50. PubMed PMID: edsgcl.231328966.
  • Iyer VN, Mandrekar JN, Danielson RD, Zubkov AY, Elmer JL, Wijdicks EF. Validity of the FOUR score coma scale in the medical intensive care unit. Mayo Clin Proc. 2009 Aug;84(8):694–701. doi: 10.1016/S0025-6196(11)60519-3. PubMed PMID: 19648386; PubMed Central PMCID: PMC2719522.
  • Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996 Aug;27(8):1304–5. PubMed PMID: 8711791.
  • Webb AJS, Ullman NL, Morgan TC, et al. Accuracy of the ABC/2 Score for Intracerebral Hemorrhage: systematic Review and Analysis of MISTIE, CLEAR-IVH, and CLEAR III [Article]. Stroke. 2015 September 28;46(9):2470–2476. PubMed PMID: edselc.2-52.0-84940434550; English.
  • Zimmerman RD, Maldjian JA, Brun NC, et al. Radiologic estimation of hematoma volume in intracerebral hemorrhage trial by CT scan [Article]. Am J Neuroradiol. 2006 March 01;27(3):666–670. PubMed PMID: edselc.2-52.0-33745907544; English.
  • Steinbrich W, Gross-Fengels W, Krestin GP, et al. [Intracranial hemorrhages in the magnetic resonance tomogram. Studies on sensitivity, on the development of hematomas and on the determination of the cause of the hemorrhage]. Rofo: Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin. 1990;152(5):534–543. PubMed PMID: 2160685.
  • Fiebach JB, Schellinger PD, Gass A, et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke. 2004;35(2):502–506. 00392499. PubMed PMID: 119721447. Corporate Author: Kompetenznetzwerk Schlaganfall B5. Language: English. Entry Date: 20040910. Revision Date: 20161126. Publication Type: journal article. Journal Subset: Allied Health. .
  • Linfante I, Llinas RH, Caplan LR, et al. MRI features of intracerebral hemorrhage within 2 hours from symptom onset [Article]. Stroke. 1999 January 01;30(11):2263–2267. PubMed PMID: edselc.2-52.0-0032744989; English.
  • Schellinger PD, Jansen O, Fiebach JB, et al. A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage [Article]. Stroke. 1999 January 01;30(4):765–768. PubMed PMID: edselc.2-52.0-0032952199; English.
  • Kidwell CS, Demchuk AM, Luby ML, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. Jama. 2004;292(15):1823. PubMed PMID: edsgcl.124727085.
  • Wijman CAC, Venkatasubramanian C, Schwartz N, et al. Utility of early MRI in the diagnosis and management of acute spontaneous intracerebral hemorrhage [Article]. Cerebrovascular Dis. 2010 October 01;30(5):456–463. PubMed PMID: edselc.2-52.0-77956088104; English.
  • Heit JJ, Iv M, Wintermark M. Imaging of Intracranial Hemorrhage. PubMed PMID: 28030895 J Stroke. 2017;191:11–27.
  • Macellari F, Paciaroni M, Agnelli G, et al. Neuroimaging in intracerebral hemorrhage. Stroke. 2014;45(3):903–908. PubMed PMID: 24425128.
  • Wilson D, Adams ME, Robertson F, et al. Investigating intracerebral haemorrhage. BMJ (Clin Res Ed). 2015;350:h2484–h2484. PubMed PMID: 25994363.
  • Lummel N, Lutz J, Bruckmann H, et al. The value of magnetic resonance imaging for the detection of the bleeding source in non-traumatic intracerebral haemorrhages: a comparison with conventional digital subtraction angiography [Report]. Neuroradiology.2012;(7):673. PubMed PMID: edsgcl.294284435.
  • Zhu XL, Chan MS, Poon WS. Spontaneous intracranial hemorrhage: which patients need diagnostic cerebral angiography? A prospective study of 206 cases and review of the literature. Stroke. 1997;28(7): 1406–1409. PubMed PMID: 9227692.
  • Bekelis K, Desai A, Eskey C, et al. Computed tomography angiography: improving diagnostic yield and cost effectiveness in the initial evaluation of spontaneous nonsubarachnoid intracerebral hemorrhage [Article]. J Neurosurg. 2012 October 01;117(4):761–766. PubMed PMID: edselc.2-52.0-84868375293; English.
  • Khosravani H, Mayer SA, Demchuk A, et al. Emergency noninvasive angiography for acute intracerebral hemorrhage. AJNR Am J Neuroradiol. 2013;34(8):1481–1487. PubMed PMID: 23124634.
  • Yoon DY, Chang SK, Choi CS, et al. Multidetector row CT angiography in spontaneous lobar intracerebral hemorrhage: A prospective comparison with conventional angiography [Article]. Am J Neuroradiol. 2009 May 01;30(5):962–967. PubMed PMID: edselc.2-52.0-65949121399; English.
  • Delgado Almandoz JE, Schaefer PW, Lev MH, et al. Practical scoring system for the identification of patients with intracerebral hemorrhage at highest risk of harboring an underlying vascular etiology: the secondary intracerebral hemorrhage score [Article]. Am J Neuroradiol. 2010 October 01;31(9):1653–1660. PubMed PMID: edselc.2-52.0-77958532589; English.
  • Broderick JP, Brott TG, Duldner JE, et al. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24(7):987–993. PubMed PMID: 8322400.
  • Fujii Y, Tanaka R, Takeuchi S, et al. Hematoma enlargement in spontaneous intracerebral hemorrhage [Article]. J Neurosurg. 1994 January 01;80(1):51–57. PubMed PMID: edselc.2-52.0-0028096082; English.
  • Brouwers HB, Greenberg SM. Hematoma expansion following acute intracerebral hemorrhage. PubMed PMID: 23466430 Cerebrovasc Dis. 2013;353:195–201.
  • Wada R, Aviv RI, Fox AJ, et al. CT angiography “spot sign” predicts hematoma expansion in acute intracerebral hemorrhage [Article]. Stroke. 2007 April 01;38(4):1257–1262. PubMed PMID: edselc.2-52.0-34247897285; English.
  • Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 2012;11(4):307–314. PubMed PMID: 22405630.
  • Goldstein JN, Fazen LE, Snider R, et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology. 2007;68(12):889–894. PubMed PMID: 105926214. Language: English. Entry Date: 20080111. Revision Date: 20170412. Publication Type: journal article.
  • Becker KJ, Baxter AB, Cohen WA, et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology. 2001;56(6):766–772. PubMed PMID: 11274312.
  • Selariu E, Abul-Kasim K, Zia E, et al. Swirl sign in intracerebral haemorrhage: definition, prevalence, reliability and prognostic value [Article]. BMC Neurol. 2012 September 26;12. PubMed PMID: edselc.2-52.0-84866544607; English.
  • Boulouis G, Morotti A, Bart Brouwers H, et al. Association between hypodensities detected by computed tomography and hematoma expansion in patients with intracerebral hemorrhage [Article]. JAMA Neurol. 2016 August 01;73(8):961–968. PubMed PMID: edselc.2-52.0-84981250484; English.
  • Boulouis G, Morotti A, Goldstein JN, et al. Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials [Article]. J Neurol Neurosurg Psychiatry. 2017 April 01;88(4):339–345. PubMed PMID: edselc.2-52.0-85016927574; English.
  • Li Q, Yang WS, Wang XC, et al. Island sign: an imaging predictor for early hematoma expansion and poor outcome in patients with intracerebral hemorrhage [Article]. Stroke. 2017 November 01;48(11):3019–3025. PubMed PMID: edselc.2-52.0-85032164190; English.
  • Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage [Article]. Crit Care Med. 2001 January 01;29(3):635–640.. PubMed PMID: edselc.2-52.0-0035100660; English.
  • Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005 Feb 24;352(8):777–785. PubMed PMID: 15728810; eng.
  • Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage [Clinical report]. N Engl J Med. 2008;358(20):2127. PubMed PMID: edsgcl.179405762.
  • Mayer SA, Davis SM, Skolnick BE, et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke. 2009;40(3):833–840. PubMed PMID: 19150875.
  • Huynh TJ, Flaherty ML, Gladstone DJ, et al. Multicenter accuracy and interobserver agreement of spot sign identification in acute intracerebral hemorrhage. Stroke. 2014 January;45(1):107. 00392499.
  • Gladstone D, Aviv R, Demchuk A, et al., editor. Randomized trial of hemostatic therapy for ‘spot sign’positive intracerebral hemorrhage: primary results from the SPOTLIGHT/STOP-IT study collaboration. Presented at the International Stroke Conference 2018, Los Angeles, California, USA, on Feb 24, 2018.
  • Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23–32. PubMed PMID: 20554319.
  • Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377(9771):1096. PubMed PMID: 21439633.
  • Sprigg N, Flaherty K, Appleton JP, et al. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018;(10135). PubMed PMID: edsgcl.540304132. DOI:10.1016/S0140-6736(18)31033-X
  • Gayet-Ageron A, Prieto-Merino D, Ker K, et al. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet. 2018;391(10116):125–132. PubMed PMID: 29126600.
  • Ohwaki K, Yano E, Nagashima H, et al. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement [Article]. Stroke. 2004 June 01;35(6):1364–1367. PubMed PMID: edselc.2-52.0-2542545213; English.
  • Willmot M, Leonardi-Bee J, Bath PMW. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertens. 2004;43(1): 18–24. PubMed PMID: 14662649.
  • Kingman TA, Mendelow AD, Graham DI, et al. Experimental intracerebral mass: time-related effects on local cerebral blood flow. J Neurosurg. 1987;67(5):732–738. PubMed PMID: 2444680.
  • Sinar EJ, Mendelow AD, Graham DI, et al. Experimental intracerebral hemorrhage: effects of a temporary mass lesion. J Neurosurg. 1987;66(4):568–576. PubMed PMID: 3559723.
  • Mayer SA, Fink ME, Thomas CE, et al. Perilesional blood flow and edema formation in acute intracerebral hemorrhage: A SPECT study [Article]. Stroke. 1998 January 01;29(9):1791–1798. PubMed PMID: edselc.2-52.0-0031662796; English.
  • Menon RS, Burgess RE, German L, et al. Predictors of highly prevalent brain ischemia in intracerebral hemorrhage [Article]. Ann Neurol. 2012 February 01;71(2):199–205. PubMed PMID: edselc.2-52.0-84857547360; English.
  • Butcher K, Selim M. Acute blood pressure management in intracerebral hemorrhage [Article]. Stroke. 2016 December 01;47(12):3065–3066.. PubMed PMID: edselc.2-52.0-84995470055; English.
  • Kate MP, Hansen MB, Mouridsen K, et al. Blood pressure reduction does not reduce perihematoma oxygenation: a CT perfusion study. J Cereb Blood Flow Metab. 2014 January;34(1):81.
  • McCourt R, Gould B, Kate M, et al. Cerebral perfusion pressure is maintained in acute intracerebral hemorrhage: A CT perfusion study [Article]. Am J Neuroradiol. 2016 February 01;37(2):244–251. PubMed PMID: edselc.2-52.0-84957991154; English.
  • Anderson CS, Davis SM, Woodward M, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage [Report]. N Engl J Med. 2013;(25): PubMed PMID: edsgcl.338153485, 2355.
  • Qureshi AI, Palesch YY, Barsan WG, et al. Intensive blood pressure-lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375(11):1033. PubMed PMID: edsgcl.465767050.
  • Anderson CS, Selim MH, Molina CA, et al. Intensive blood pressure lowering in intracerebral hemorrhage [Article]. Stroke. 2017 July 01;48(7):2034–2037. PubMed PMID: edselc.2-52.0-85021174779; English.
  • Steiner T, Salman RA-S, Beer R, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage [Article]. Int J Stroke . 2014;9(7):840–855. PubMed PMID: 103411940.
  • Shinohara Y, Yanagihara T, Abe K, et al. Intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2011;20(4 Suppl):S74–S99. PubMed PMID: 21835358.
  • Williams B, Mancia G, Spiering W, et al. ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension: the task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension [Author abstract]. J Hypertens. 2018;2018(10):1953. PubMed PMID: edsgcl.554824338.
  • Veltkamp R, Rizos T, Horstmann S. Intracerebral bleeding in patients on antithrombotic agents [Article]. PubMed PMID: 91710712 Semin Thromb Hemost. 2013;398:963–971.
  • Rabinstein AA, Wijdicks EFM. Determinants of outcome in anticoagulation-associated cerebral hematoma requiring emergency evacuation. Arch Neurol. 2007;64(2): 203–206. PubMed PMID: 17172604.
  • Bower MM, Sweidan AJ, Shafie M, et al. Contemporary reversal of oral anticoagulation in intracerebral hemorrhage. Stroke. 2019;50(2):529–536. PubMed PMID: 30636573.
  • Leissinger CA, Blatt PM, Hoots WK, et al. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol. 2008;83(2):137–143. PubMed PMID: 17729241.
  • Riess HB, Meier-Hellmann A, Motsch J, et al. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. Thromb Res. 2007;121(1):9–16. PubMed PMID: 17407788.
  • Pabinger I, Brenner B, Kalina U, et al. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost. 2008;6(4):622–631. PubMed PMID: 18208533.
  • Büller HR, Prins MH, Lensin AWA, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012;366(14):1287–1297. PubMed PMID: 22449293.
  • Agnelli G, Raskob GE, Thompson J, et al. Oral Apixaban for the treatment of acute venous thromboembolism [Report]. N Engl J Med. 2013;369(9):799. PubMed PMID: edsgcl.343868323.
  • Schulman S, Kearon C, Kakkar AK, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism [Article]. N Engl J Med. 2009 December 10;361(24):2342–2352. PubMed PMID: edselc.2-52.0-71849117615; English.
  • Pollack CV Jr., Reilly PA, Eikelboom J, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015 Aug 6;373(6):511–520. PubMed PMID: 26095746; eng.
  • Stuart JC, Michael DE, Salim Y, et al. Dabigatran versus Warfarin in patients with atrial fibrillation. N Engl J Med. 2009; (12): 1139. PubMed PMID: edsovi.00006024.200909170.00005. DOI:10.1056/NEJMoa0905561
  • Connolly SJ, Jr MTJ, Eikelboom JW, et al. Andexanet Alfa for acute major bleeding associated with factor Xa inhibitors [article]. 2016; (12). UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/40w2w6c9. PubMed PMID: edssch.qt40w2w6c9. DOI:10.1056/NEJMoa1607887.10.1056/NEJMoa1607887
  • Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, Yue P, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Demchuk AM, Pallin DJ, Concha M, Goodman S, Leeds J, Souza S, Siegal DM, Zotova E, Meeks B, Ahmad S, Nakamya J, Milling TJ Jr; ANNEXA-4 Investigators. Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors. N Engl J Med. 2019 Apr 4;380(14):1326–1335. Doi:10.1056/NEJMoa1814051. Epub 2019 Feb 7. PubMed PMID: 30730782.
  • Hu TY, Vaidya VR, Asirvatham SJ. Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab. Vasc Health Risk Manag. 2016 Feb 17;12:35-44. Doi:10.2147/VHRM.S89130. PubMed PMID: 26937198; PubMed Central PMCID: PMC4762436.
  • Levy JH, Cormack JG, Morales A. Heparin neutralization by recombinant platelet factor 4 and protamine. Anesth Analg. 1995;81(1): 35–37. PubMed PMID: 7598278.
  • Racanelli A, Fareed J. Neutralization of the antithrombotic effects of heparin and Fraxiparin by protamine sulfate. Thromb Res. 1992 Nov 1;68(3):211–222. PubMed PMID: 1471069; eng.
  • Dehmer GJ, Haagen D, Malloy CR, et al. Anticoagulation with heparin during cardiac catheterization and its reversal by protamine. Catheterization Cardiovasc Diagn. 1987;13(1):16–21. PubMed PMID: 3815512.
  • Gatti G, Pugliese P. Heparin reversal in off-pump coronary artery bypass surgery: complete, partial, or no reversal? Cardiovasc Surg. 2002;10(3): 245–250. PubMed PMID: 12044433.
  • Frontera JA, Lewin JJ, Rabinstein AA, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: executive summary. a statement for healthcare professionals from the neurocritical care society and the society of critical care medicine [Article]. Crit Care Med. 2016 December 01;44(12):2251–2257. PubMed PMID: edselc.2-52.0-84995684276; English.
  • Dolovich LR, Ginsberg JS, Douketis JD, et al. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Internal Med. 2000;160(2):181–188. PubMed PMID: 10647756.
  • Robertson L, Jones LE. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. Cochrane Database Syst Rev. 2017;2:CD001100. PubMed PMID: 28182249.
  • Mismetti P, Laporte-Simitsidis S, Tardy B, et al. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost. 2000 Jan;83(1):14–19. PubMed PMID: 10669147; eng.
  • Gerotziafas GT, Zafiropoulos A, Van Dreden P, et al. Inhibition of factor VIIa generation and prothrombin activation by treatment with enoxaparin in patients with unstable angina. Br J Haematol. 2003;120(4):611–617. PubMed PMID: 12588347.
  • Chan S, Kong M, Minning DM, et al. Assessment of recombinant factor VIIa as an antidote for bleeding induced in the rabbit by low molecular weight heparin. J Thromb Haemost. 2003;1(4):760–765. PubMed PMID: 12871413.
  • Lauritzen B, Hedner U, Johansen PB, et al. Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats. J Thromb Haemost. 2008 May;6(5):804–811. PubMed PMID: 18315554; eng.
  • Crowther MA, Berry LR, Monagle PT, et al. Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin. Br J Haematol. 2002 Jan;116(1):178–186. PubMed PMID: 11841415; eng.
  • Gatt A, van Veen JJ, Woolley AM, et al. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro. Thromb Haemost. 2008;100(2):350–355. PubMed PMID: 18690358.
  • Diness V, Ostergaard PB. Neutralization of a low molecular weight heparin (LHN-1) and conventional heparin by protamine sulfate in rats. Thromb Haemost. 1986;56(3): 318–322. PubMed PMID: 3563964.
  • Van Ryn-McKenna J, Cai L, Ofosu FA, et al. Neutralization of enoxaparine-induced bleeding by protamine sulfate. Thromb Haemost. 1990;63(2):271–274. PubMed PMID: 2163553.
  • Makris M, Hough RE, Kitchen S. Poor reversal of low molecular weight heparin by protamine. Br J Haematol. 2000;108(4): 884–885. PubMed PMID: 10858037.
  • Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e227S–e277S. PubMed PMID: 22315263.
  • Sansing LH, Messe SR, Cucchiara BL, et al. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH [Article]. Neurology. 2009 April 21;72(16):1397–1402. PubMed PMID: edselc.2-52.0-67449124295; English.
  • Campbell PG, Sen A, Yadla S, et al. Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review. World Neurosurg. 2010;74(2–3):279–285. PubMed PMID: 21492561.
  • Naidech AM, Liebling SM, Rosenberg NF, et al. Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage. Neurocrit Care. 2012;16(1):82–87. PubMed PMID: 21837536
  • Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet . 2016;387(10038):2605–2613. PubMed PMID: 27178479.
  • Mannucci PM, Vicente V, Vianello L, et al. Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood. 1986;67(4):1148–1153. PubMed PMID: 3513867.
  • Swieringa F, Lancé MD, Fuchs B, et al. Desmopressin treatment improves platelet function under flow in patients with postoperative bleeding. J Thromb Haemost. 2015;13(8):1503–1513. PubMed PMID: 25988848.
  • Wademan BH, Galvin SD. Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults. PubMed PMID: 24263581 Interact Cardiovasc Thorac Surg. 2014;183:360–370.
  • Jin L, Ji H-W. Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. PubMed PMID: 25698197 Chin Med J (Engl). 2015;1285:644–647.
  • Naidech AM, Maas MB, Levasseur-Franklin KE, et al. Desmopressin improves platelet activity in acute intracerebral hemorrhage. Stroke. 2014;45(8):2451–2453. PubMed PMID: 25005444.
  • Kapapa T, Rohrer S, Struve S, et al. Desmopressin acetate in intracranial haemorrhage. Neurol Res Int. 2014;2014:298767. PubMed PMID: 25610644; PubMed Central PMCID: PMCPMC4290038. eng.
  • de Oliveira Manoel AL, Goffi A, Zampieri FG, et al. The critical care management of spontaneous intracranial hemorrhage: a contemporary review. Crit Care. 2016;20:272. PubMed PMID: 27640182.
  • Li X, Sun Z, Zhao W, et al. Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage. J Neurosurg. 2013;118(1):94–103. PubMed PMID: 23082885.
  • Urday S, Kimberly WT, Beslow LA, et al. Targeting secondary injury in intracerebral haemorrhage–perihaematomal oedema [Report]. Nat Rev Neurol. 2015; (2): 111. PubMed PMID: edsgcl.401906188. DOI:10.1038/nrneurol.2014.264
  • Selim M, Norton C. Perihematomal edema: implications for intracerebral hemorrhage research and therapeutic advances. J Neurosci Res. 2018. PubMed PMID: 30575082. DOI:10.1002/jnr.24372
  • Venkatasubramanian C, Mlynash M, Finley-Caulfield A, et al. Natural history of perihematomal edema after intracerebral hemorrhage measured by serial magnetic resonance imaging. Stroke. 2011 Jan;42(1):73–80. PubMed PMID: 21164136; PubMed Central PMCID: PMCPMC3074599. eng.
  • Gebel JM Jr., Jauch EC, Brott TG, et al. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke. 2002;33(11):2636–2641. PubMed PMID: 12411654.
  • Vicenzini E, Ricciardi MC, Zuco C, et al. Effects of a single mannitol bolus on cerebral hemodynamics in intracerebral hemorrhage: a transcranial Doppler study. Cerebrovasc Dis. 2011;32(5):447–453. PubMed PMID: 22005320; eng.
  • Misra UK, Kalita J, Ranjan P, et al. Mannitol in intracerebral hemorrhage: a randomized controlled study. J Neurol Sci. 2005;234(1–2):41–45. PubMed PMID: 15936036.
  • Xia W, Hisatomi A, Jie Y, et al. Mannitol and outcome in intracerebral hemorrhage: propensity score and multivariable intensive blood pressure reduction in acute cerebral hemorrhage trial 2 results. Stroke. 2015; (10): 2762. PubMed PMID: edsovi.10.1161.STROKEAHA.115.009357. DOI:10.1161/STROKEAHA.115.009357.
  • Qureshi AI, Wilson DA, Traystman RJ. Treatment of transtentorial herniation unresponsive to hyperventilation using hypertonic saline in dogs: effect on cerebral blood flow and metabolism [Article]. J Neurosurg Anesthesiol. 2002 January 01;14(1):22–30. PubMed PMID: edselc.2-52.0-0036135029; English.
  • Koenig MA, Bryan M, Lewin JL III, et al. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70(13):1023–1029. PubMed PMID: 105722359. Language: English. Entry Date: 20080523. Revision Date: 20150711. Publication Type: Journal Article.
  • Wagner I, Hauer E-M, Staykov D, et al. Effects of continuous hypertonic saline infusion on perihemorrhagic edema evolution. Stroke. 2011;42(6):1540–1545. PubMed PMID: 21512173.
  • Kamel H, Navi BB, Nakagawa K, et al. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med. 2011;39(3):554–559. PubMed PMID: 104824008. Language: English. Entry Date: 20110422. Revision Date: 20161119. Publication Type: journal article.
  • Asehnoune K, Lasocki S, Seguin P, et al. Association between continuous hyperosmolar therapy and survival in patients with traumatic brain injury - a multicentre prospective cohort study and systematic review [Clinical report]. Crit Care. 2017; (1). PubMed PMID: edsgcl.546082191. DOI:10.1186/s13054-017-1918-4.
  • Gonda DD, Meltzer HS, Crawford JR, et al. Complications associated with prolonged hypertonic saline therapy in children with elevated intracranial pressure. Pediatr Crit Care Med. 2013;14(6):610–620. PubMed PMID: 23823197.
  • Mangat HS. Hypertonic saline infusion for treating intracranial hypertension after severe traumatic brain injury. PubMed PMID: 29463291 Crit Care. 2018;221:37.
  • Poungvarin N, Bhoopat W, Viriyavejakul A, et al. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage [Article]. N Engl J Med. 1987 May 14;316(20):1229–1233. PubMed PMID: edselc.2-52.0-0023175662; English.
  • Hemphill JC 3rd, Bonovich DC, Besmertis L, et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001 Apr;32(4):891–897. PubMed PMID: 11283388; eng.
  • Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001 May 10;344(19):1450–1460. PubMed PMID: 11346811; eng.
  • Kamel H, Hemphill JC 3rd. Characteristics and sequelae of intracranial hypertension after intracerebral hemorrhage. Neurocrit Care. 2012 Oct;17(2):172–176.. PubMed PMID: 22833445.
  • Hanley DF, Lane K, McBee N, et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017;(10069). PubMed PMID: edsgcl.520006947. DOI:10.1016/S0140-6736(16)32410-2
  • Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet. 2005;365(9457):387–397..
  • Mendelow AD, Gregson BA, Rowan EN, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013;382(9890):397–408.
  • Takeuchi S, Wada K, Nagatani K, et al. Decompressive hemicraniectomy for spontaneous intracerebral hemorrhage. Neurosurg Focus. 2013 May;34(5):E5. PubMed PMID: 23634924.
  • Heuts SG, Bruce SS, Zacharia BE, et al. Decompressive hemicraniectomy without clot evacuation in dominant-sided intracerebral hemorrhage with ICP crisis. Neurosurg Focus. 2013 May;34(5):E4. PubMed PMID: 23634923.
  • Luney MS, English SW, Longworth A, et al. Acute posterior cranial fossa hemorrhage–is surgical decompression better than expectant medical management? [Report]. Neurocrit Care. 2016; (3): 365. PubMed PMID: edsgcl.472852941. DOI:10.1007/s12028-015-0217-7
  • Da Pian R, Bazzan A, Pasqualin A. Surgical versus medical treatment of spontaneous posterior fossa haematomas: a cooperative study on 205 cases. Neurol Res. 1984 Sep;6(3):145–151. PubMed PMID: 6151139; eng.
  • Ott KH, Kase CS, Ojemann RG, et al. Cerebellar hemorrhage: diagnosis and treatment. A review of 56 cases. Arch Neurol. 1974 Sep;31(3):160–167. PubMed PMID: 4546748; eng.
  • Young WB, Lee KP, Pessin MS, et al. Prognostic significance of ventricular blood in supratentorial hemorrhage: a volumetric study. Neurology. 1990 Apr;40(4):616–619. PubMed PMID: 2320234; eng.
  • Tuhrim S, Horowitz DR, Sacher M, et al. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med. 1999 Mar;27(3):617–621. PubMed PMID: 10199544; eng.
  • Naff N, Williams MA, Keyl PM, et al. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke. 2011 Nov;42(11):3009–3016. PubMed PMID: 21868730; PubMed Central PMCID: PMCPMC3356690.
  • Hanley DF, Thompson RE, Muschelli J, et al. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016;15(12):1228–1237.
  • Mould WA, Carhuapoma JR, Muschelli J, et al. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke. 2013 Mar;44(3):627–634. PubMed PMID: 23391763; PubMed Central PMCID: PMCPMC4124642.
  • Hanley DF, Thompson RE, Rosenblum M, et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019;393(10175):1021–1032.
  • Kellner CP, Chartrain AG, Nistal DA, et al. The Stereotactic Intracerebral Hemorrhage Underwater Blood Aspiration (SCUBA) technique for minimally invasive endoscopic intracerebral hemorrhage evacuation. J Neurointerv Surg. 2018 Aug;10(8):771–776. PubMed PMID: 29572265; PubMed Central PMCID: PMCPMC6278654.
  • Vespa P, Hanley D, Betz J, et al. ICES (Intraoperative stereotactic computed tomography-guided endoscopic surgery) for brain hemorrhage: a multicenter randomized controlled trial. Stroke. 2016 Nov;47(11):2749–2755. PubMed PMID: 27758940; PubMed Central PMCID: PMCPMC6168060.
  • Szaflarski JP, Rackley AY, Kleindorfer DO, et al. Incidence of seizures in the acute phase of stroke: a population-based study. Epilepsia. 2008 Jun;49(6):974–981. PubMed PMID: 18248443; PubMed Central PMCID: PMCPMC5316476.
  • Claassen J, Jette N, Chum F, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007 Sep 25;69(13):1356–1365. PubMed PMID: 17893296; eng.
  • Gilmore EJ, Maciel CB, Hirsch LJ, et al. Review of the utility of prophylactic anticonvulsant use in critically Ill patients with intracerebral hemorrhage. Stroke. 2016 Oct;47(10):2666–2672. PubMed PMID: 27608820.
  • Naidech AM, Garg RK, Liebling S, et al. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke. 2009 Dec;40(12):3810–3815. PubMed PMID: 19797183.
  • Sheth KN, Martini SR, Moomaw CJ, et al. Prophylactic antiepileptic drug use and outcome in the ethnic/racial variations of intracerebral hemorrhage study. Stroke. 2015 Dec;46(12):3532–3535. PubMed PMID: 26470777; PubMed Central PMCID: PMCPMC4659755.
  • Reddig RT, Nixdorf KE, Jensen MB. The prophylactic use of an antiepileptic drug in intracerebral hemorrhage. Clin Neurol Neurosurg. 2011 Dec;113(10):895–897.. PubMed PMID: 21824722; PubMed Central PMCID: PMCPMC3215779.
  • Rosenthal J, Lord A, Ishida K, et al. Highest in-hospital glucose measurements are associated with neurological outcomes after intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2662–2668. PubMed PMID: 30045809.
  • Saxena A, Anderson CS, Wang X, et al. Prognostic significance of hyperglycemia in acute intracerebral hemorrhage: the INTERACT2 study. Stroke. 2016 Mar;47(3):682–688. PubMed PMID: 26814235.
  • Zheng J, Yu Z, Ma L, et al. Association between blood glucose and functional outcome in intracerebral hemorrhage: a systematic review and meta-analysis. World Neurosurg. 2018 Jun;114:e756–e765. PubMed PMID: 29555604.
  • Guo X, Li H, Zhang Z, et al. Hyperglycemia and mortality risk in patients with primary intracerebral hemorrhage: a meta-analysis. Mol Neurobiol. 2016 May;53(4):2269–2275. PubMed PMID: 25972238.
  • Oddo M, Schmidt JM, Carrera E, et al. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med. 2008 Dec;36(12):3233–3238. PubMed PMID: 18936695.
  • Greer DM, Funk SE, Reaven NL, et al. Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke. 2008 Nov;39(11):3029–3035. PubMed PMID: 18723420.
  • Rincon F, Lyden P, Mayer SA. Relationship between temperature, hematoma growth, and functional outcome after intracerebral hemorrhage. Neurocrit Care. 2013 Feb;18(1):45–53. PubMed PMID: 23001769.
  • Fischer M, Schiefecker A, Lackner P, et al. Targeted temperature management in spontaneous intracerebral hemorrhage: a systematic review. Curr Drug Targets. 2017;18(12):1430–1440. PubMed PMID: 27397065; eng.
  • Rincon F, Friedman DP, Bell R, et al. Targeted temperature management after intracerebral hemorrhage (TTM-ICH): methodology of a prospective randomized clinical trial. Int J Stroke. 2014 Jul;9(5):646–651. PubMed PMID: 24450819.
  • Kollmar R, Juettler E, Huttner HB, et al. Cooling in intracerebral hemorrhage (CINCH) trial: protocol of a randomized German-Austrian clinical trial. Int J Stroke. 2012 Feb;7(2):168–172. PubMed PMID: 22264371; eng.
  • CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration, Dennis M, Sandercock P, Reid J, Graham C, Forbes J, Murray G. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet. 2013 Aug 10;382(9891):516-24. Doi:10.1016/S0140-6736(13)61050–8. Epub 2013 May 31. Erratum in: Lancet. 2013 Aug 10;382(9891):506. Erratum in: Lancet. 2013 Sep 21;382(9897):1020. PubMed PMID: 23727163.
  • Ianosi B, Gaasch M, Rass V, et al. Early thrombosis prophylaxis with enoxaparin is not associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage. Eur J Neurol. 2019 Feb;26(2):333–341. PubMed PMID: 30308696.
  • Wu J, Hua Y, Keep RF, et al. Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke. 2003;34(12):2964–2969. 00392499. PubMed PMID: 119721345. Language: English. Entry Date: 20040903. Revision Date: 20161128. Publication Type: journal article. Journal Subset: Allied Health.
  • Huang F-P, Xi G, Keep RF, et al. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg. 2002;96(2):287–293. PubMed PMID: 11838803.
  • Goldstein L, Teng ZP, Zeserson E, et al. Hemin induces an iron-dependent, oxidative injury to human neuron-like cells [Article]. J Neurosci Res. 2003 July 01;73(1):113–121. PubMed PMID: edselc.2-52.0-0037716283; English.
  • Selim M, Foster LD, Moy CS, et al. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial [Article]. Lancet Neurol. 2019;18(5):428–438. PubMed PMID: 135889468.
  • An SJ, Kim TJ, Yoon BW. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke. 2017 Jan;19(1):3–10.. PubMed PMID: 28178408; PubMed Central PMCID: PMCPMC5307940.
  • Clarke JL, Johnston SC, Farrant M, et al. External validation of the ICH score. Neurocrit Care. 2004;1(1):53–60. PubMed PMID: 16174898; eng.
  • Mattishent K, Kwok CS, Ashkir L, et al. Prognostic tools for early mortality in hemorrhagic stroke: systematic review and meta-analysis. J Clin Neurol. 2015 Oct;11(4):339–348. PubMed PMID: 26256658; PubMed Central PMCID: PMCPMC4596099. eng.
  • Morgenstern LB, Zahuranec DB, Sanchez BN, et al. Full medical support for intracerebral hemorrhage. Neurology. 2015 Apr 28;84(17):1739–1744. PubMed PMID: 25817842; PubMed Central PMCID: PMCPMC4424123. eng.
  • Zurasky JA, Aiyagari V, Zazulia AR, et al. Early mortality following spontaneous intracerebral hemorrhage. Neurology. 2005;64(4):725–727. PubMed PMID: 15728302.
  • Hemphill JC 3rd, Newman J, Zhao S, et al. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke. 2004 May;35(5):1130–1134. PubMed PMID: 15044768.
  • Hemphill JC 3rd, White DB. Clinical nihilism in neuroemergencies. Emerg Med Clin North Am. 2009 Feb;27(1):27–37, vii-viii.. PubMed PMID: 19218017; PubMed Central PMCID: PMCPMC2676162.
  • Ansell JE, Bakhru SH, Laulicht BE, et al. Use of PER977 to reverse the anticoagulant effect of edoxaban. N Engl J Med. 2014;371(22):2141–2142. PubMed PMID: 25371966.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.